{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:30:16Z","timestamp":1777307416120,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:00:00Z","timestamp":1735084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cyto.2024.156843","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T13:04:34Z","timestamp":1735563874000},"page":"156843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring the causal relationship between inflammatory cytokines and myasthenia gravis: A two-way Mendelian randomization study"],"prefix":"10.1016","volume":"186","author":[{"given":"Jing-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Jun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Miao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Chen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.cyto.2024.156843_bb0005","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156843_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.cyto.2024.156843_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cyto.2024.156843_bb0020","doi-asserted-by":"crossref","first-page":"39716","DOI":"10.1038\/srep39716","article-title":"Profile of upregulated inflammatory proteins in sera of myasthenia gravis patients","volume":"7","author":"Molin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2024.156843_bb0025","doi-asserted-by":"crossref","first-page":"1110499","DOI":"10.3389\/fimmu.2023.1110499","article-title":"Inflammation and autoimmune myasthenia gravis","volume":"14","author":"Huda","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156843_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577279","article-title":"Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis","volume":"345","author":"Li","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-023-02691-3","article-title":"Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis","volume":"20","author":"Villegas","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cyto.2024.156843_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122287","article-title":"Targeting HIF-1alpha alleviates the inflammatory responses and rebuilds the CD4(+) T cell subsets balance in the experimental autoimmune myasthenia gravis inflammation model via regulating cellular and humoral immunity","volume":"336","author":"Yu","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.cyto.2024.156843_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10238-015-0358-1","article-title":"Decreased microRNA miR-181c expression in peripheral blood mononuclear cells correlates with elevated serum levels of IL-7 and IL-17 in patients with myasthenia gravis","volume":"16","author":"Zhang","year":"2016","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5507\/bp.2019.009","article-title":"Upregulation of miR150-5p in generalized myasthenia gravis patients is associated with decreased serum levels of IL-17 and increased serum levels of IL-10","volume":"164","author":"Ao","year":"2020","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"issue":"7","key":"10.1016\/j.cyto.2024.156843_bb0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156843_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103210","article-title":"Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases","volume":"21","author":"Chen","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2024.156843_bb0065","doi-asserted-by":"crossref","unstructured":"Richmond, R.C. and G. Davey Smith, Mendelian Randomization: Concepts and Scope. Cold Spring Harb Perspect Med, 2022. vol. 12(1).","DOI":"10.1101\/cshperspect.a040501"},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0070","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/ije\/dyw079","article-title":"Using Mendelian randomization to investigate a possible causal relationship between adiposity and increased bone mineral density at different skeletal sites in children","volume":"45","author":"Kemp","year":"2016","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108672119","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study","volume":"119","author":"Chia","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cyto.2024.156843_bb0090","article-title":"Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: a Mendelian randomization","volume":"13","author":"Xiang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156843_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.942861","article-title":"Age at menarche and ischemic heart disease: an update mendelian randomization study","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0100","doi-asserted-by":"crossref","first-page":"2291885","DOI":"10.1080\/19382014.2023.2291885","article-title":"The causal relationship between bacterial pneumonia and diabetes: a two-sample mendelian randomization study","volume":"16","author":"Pan","year":"2024","journal-title":"Islets"},{"issue":"3","key":"10.1016\/j.cyto.2024.156843_bb0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cyto.2024.156843_bb0110","first-page":"7","article-title":"The MR-base platform supports systematic causal inference across the human phenome","author":"Hemani","year":"2018","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.cyto.2024.156843_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5808\/GI.2016.14.4.173","article-title":"Comparison of two Meta-analysis methods: inverse-variance-weighted average and weighted sum of Z-scores","volume":"14","author":"Lee","year":"2016","journal-title":"Genomics Inform"},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156843_bb0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.cyto.2024.156843_bb0130","article-title":"Inflammatory cytokines and risk of ischemic stroke: a Mendelian randomization study","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cyto.2024.156843_bb0135","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00404-023-07302-3","article-title":"Causal associations of insomnia and postpartum depression: a two-sample mendelian randomization study","volume":"310","author":"Shen","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.cyto.2024.156843_bb0140","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cyto.2024.156843_bb0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.seizure.2023.11.006","article-title":"Exploring causal correlations between systemic inflammatory cytokines and epilepsy: a bidirectional Mendelian randomization study","volume":"114","author":"Sun","year":"2023","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cyto.2024.156843_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156843_bb0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2024.156843_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/740947","article-title":"Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg treatments","volume":"2014","author":"Li","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2024.156843_bb0175","first-page":"1","article-title":"Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis","volume":"158","author":"Link","year":"1994","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"4","key":"10.1016\/j.cyto.2024.156843_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cytogfr.2014.07.013","article-title":"IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: current and future developments","volume":"25","author":"Luchtman","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0185","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.183.5.2349","article-title":"Cloning, expression, and characterization of the human eosinophil eotaxin receptor","volume":"183","author":"Daugherty","year":"1996","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.cyto.2024.156843_bb0190","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0960-9822(06)00371-X","article-title":"Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils","volume":"7","author":"Gerber","year":"1997","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0195","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12936-022-04372-7","article-title":"Eotaxin-2 and eotaxin-3 in malaria exposure and pregnancy","volume":"21","author":"Mancebo-Perez","year":"2022","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.cyto.2024.156843_bb0200","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood-2002-09-2773","article-title":"Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes","volume":"102","author":"Ogilvie","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2024.156843_bb0205","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1084\/jem.183.6.2437","article-title":"Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils","volume":"183","author":"Ponath","year":"1996","journal-title":"J. Exp. Med."},{"issue":"5334","key":"10.1016\/j.cyto.2024.156843_bb0210","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0215","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI119624","article-title":"High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines","volume":"100","author":"Uguccioni","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2024.156843_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105800","article-title":"Immunologic analysis of CSF in patients with de novo diagnosed RRMS. The role of chemokines in the early phase of the disease","volume":"90","author":"Gebka-Kepinska","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.cyto.2024.156843_bb0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymeth.2023.11.003","article-title":"T helper (Th) cell profiles and cytokines\/chemokines in characterization, treatment, and monitoring of autoimmune diseases","volume":"220","author":"Ayass","year":"2023","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.cyto.2024.156843_bb0230","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"Uzawa","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156843_bb0235","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3109\/02770903.2014.917659","article-title":"CCL11 as a potential diagnostic marker for asthma?","volume":"51","author":"Wu","year":"2014","journal-title":"J. Asthma"},{"issue":"5889","key":"10.1016\/j.cyto.2024.156843_bb0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/300267a0","article-title":"A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor","volume":"300","author":"Leonard","year":"1982","journal-title":"Nature"},{"issue":"4778","key":"10.1016\/j.cyto.2024.156843_bb0245","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.3095922","article-title":"Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions","volume":"234","author":"Sharon","year":"1986","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4049\/jimmunol.0900691","article-title":"The initial phase of an immune response functions to activate regulatory T cells","volume":"183","author":"O\u2019Gorman","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0255","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2024.156843_bb0260","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156843_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2015.09.005","article-title":"Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells","volume":"67","author":"Aricha","year":"2016","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004137","article-title":"IL2RA\/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D)","volume":"4","author":"Alcina","year":"2009","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.cyto.2024.156843_bb0275","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.434","article-title":"Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource","volume":"41","author":"Dendrou","year":"2009","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cyto.2024.156843_bb0280","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.24187","article-title":"Association of the IL2RA\/CD25 gene with juvenile idiopathic arthritis","volume":"60","author":"Hinks","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.cyto.2024.156843_bb0285","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ng2102","article-title":"Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes","volume":"39","author":"Lowe","year":"2007","journal-title":"Nat. Genet."},{"issue":"26","key":"10.1016\/j.cyto.2024.156843_bb0290","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","article-title":"Shared and distinct genetic variants in type 1 diabetes and celiac disease","volume":"359","author":"Smyth","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cyto.2024.156843_bb0295","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni0901-816","article-title":"Regulatory T cells in the control of immune pathology","volume":"2","author":"Maloy","year":"2001","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cyto.2024.156843_bb0305","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.cyto.2024.156843_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083811","article-title":"Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients","volume":"8","author":"Cerosaletti","year":"2013","journal-title":"PloS One"},{"issue":"7145","key":"10.1016\/j.cyto.2024.156843_bb0315","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control, C","year":"2007","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cyto.2024.156843_bb0320","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1089\/gtmb.2013.0291","article-title":"Polymorphisms in the IL2RA and IL2RB genes in inflammatory bowel disease risk","volume":"17","author":"Bouzid","year":"2013","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"9","key":"10.1016\/j.cyto.2024.156843_bb0325","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624003478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624003478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:41:20Z","timestamp":1737322880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624003478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":65,"alternative-id":["S1043466624003478"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156843","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the causal relationship between inflammatory cytokines and myasthenia gravis: A two-way Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156843"}}